Endonovo Therapeutics Inc (ENDV)

[midas716]

I told everyone a while back. I have friends on wall street. I live in NYC. They are all aware of ENDV. They will not invest because:

70% increase in Issued and Outstanding shares. 91 million in last quarter alone.

They do not care about Pre-Clinicals by an "un-named" facility. They care about verifiable results.

They "know" the mm's are not manipulating the PPS. A group of traders created the MOMO and are now selling off.

Way too much selling into the bid when bid support grows to allow the selling without hurting the bid.

The company has not secured the financing 6 months after PRing it so they have not addressed the convertible debt.

They most certainly cannot up-list as PR'd by the end of second quarter.

The company has not done 1 thing they have PR'd other than announce unverified Pre-Clinicals.

Volume is almost at pre-run levels meaning retail is no longer buying and when they attempt it's at the bid where the sellers are selling into. No way for a stocks share price to increase like that and it scares away retail.

So after all this why would the street even touch this let alone retail. Speculation? As one of my friends put it. "Speculation can make you or break you." "Too much risk for the street at this time." "Maybe when it hits .50+ on verified Pre-Clinical results or they up-list to a higher exchange." "The street doesn't care if it pays .10 or .50. as long as there is some kind of catalyst to steadily increase the share price."